Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Spine SABR - Dose-escalated Stereotactic Ablative Body Radiotherapy (SABR) for Solid Tumour Spine Metastases

NCT06078813 is registered in ClinicalTrials.gov with Cancer Trials Ireland as lead sponsor.

NCT NCT06078813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06078813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Spine SABR - Dose-escalated Stereotactic Ablative Body Radiotherapy (SABR) for Solid Tumour Spine Metastases
Lead sponsor
Cancer Trials Ireland
Phase
Phase 1/2
Overall status
Recruiting
Start date
November 21, 2023
Completion date
April 1, 2034
Enrollment
126 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor spine metastases